AA
OSIR

ALPS Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

ALPS Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-38,746
Closed -$221K – 659
2016
Q1 		$221K Sell
38,746
-6,641
-15% -$46.4K ﹤0.01% 599
2015
Q4 		$471K Sell
45,387
-8,443
-16% -$115K ﹤0.01% 509
2015
Q3 		$9.94K Buy
53,830
+19,697
+58% +$380K 0.01% 216
2015
Q2 		$664K Buy
34,133
+17,106
+100% +$303K 0.01% 248
2015
Q1 		$299K Buy
+17,027
New +$286K ﹤0.01% 624

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

ALPS Advisors's OSIR Position: Q2 2016 in Review

ALPS Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 38,746 shares — an estimated $221K sold.

ALPS Advisors first reported a position in OSIR in Q1 2015 and held it in 5 quarters. The position peaked at $664K in Q2 2015. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

  • ALPS Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • ALPS Advisors sold 38,746 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $221K.
  • ALPS Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
  • ALPS Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $664K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on ALPS Advisors's 13F filing for Q2 2016, filed 27 Jul 2016.